Talking Ketamine Podcast

We move beyond depression and anesthesia to examine ketamine's role in fighting one of the most severe types of chronic pain imaginable: Complex Regional Pain Syndrome (CRPS) . This condition is marked by wildly disproportionate and persistent pain , exemplified by the case of a 15-year-old athlete whose simple hand fracture healed, but whose nervous system got stuck in a pathological pain loo...

Chronic mental illnesses like severe MDD (major depressive disorder) and PTSD are alarms, not just for the mind, but for the body. This episode explores the fact that ongoing trauma and depression accelerate biological aging , leading to reduced health span and higher risks for chronic diseases. But can rapid, effective psychiatric treatment actually reverse this damage? We dive into a compelling...

Chronic mental illnesses like severe MDD (major depressive disorder) and PTSD are alarms, not just for the mind, but for the body. This episode explores the fact that ongoing trauma and depression accelerate biological aging , leading to reduced health span and higher risks for chronic diseases. But can rapid, effective psychiatric treatment actually reverse this damage? We dive into a compelling...

The KARMA-Dep2 trial delivered a shocking headline: up to eight serial ketamine infusions were no better than the midazolam placebo for hospitalized adults with moderate to severe depression. In an era of intense hope for ketamine's rapid antidepressant effects, this result demands a closer look. This episode critically dissects why this large, pragmatic trial may have failed to show a signifi...

For years, the most recognized physical risk of chronic ketamine abuse has been bladder damage, but a new clinical puzzle is emerging: severe injury to the liver and bile ducts, known as Ketamine-induced Sclerosing Cholangitis (K-SC) . This episode dives into a recent case series detailing patients—including older and female European users—broadening the picture of who is at risk . Sclerosing chol...

For years, the most recognized physical risk of chronic ketamine abuse has been bladder damage, but a new clinical puzzle is emerging: severe injury to the liver and bile ducts, known as Ketamine-induced Sclerosing Cholangitis (K-SC) . This episode dives into a recent case series detailing patients—including older and female European users—broadening the picture of who is at risk. Sclerosing chola...

This episode breaks down a truly radical theory of consciousness: The General Resonance Theory (GRT) . Forget the traditional idea that consciousness comes from synapses firing—GRT proposes that it emerges from near-instantaneous, resonant electromagnetic field interactions within the brain, moving information up to 40,000 times faster than slow neuronal spikes. This electrical “field” is the true...

This episode breaks down a truly radical theory of consciousness: The General Resonance Theory (GRT). Forget the traditional idea that consciousness comes from synapses firing—GRT proposes that it emerges from near-instantaneous, resonant electromagnetic field interactions within the brain, moving information up to 40,000 times faster than slow neuronal spikes. This electrical "field" is t...

When stroke strikes, the damage doesn't stop once the blood flow is restored. This episode dives into the dark side of recovery: the Ischemia-Reperfusion (IR) Injury, a devastating "second wave" of damage that causes lasting neurological deficits. We explore a fascinating preclinical study on esketamine, the S-enantiomer of ketamine. Researchers hypothesized that this powerful NMDA rec...

When stroke strikes, the damage doesn’t stop once the blood flow is restored. This episode dives into the dark side of recovery: the Ischemia-Reperfusion (IR) Injury, a devastating “second wave” of damage that causes lasting neurological deficits. We explore a fascinating preclinical study on esketamine, the S-enantiomer of ketamine. Researchers hypothesized that this powerful NMDA receptor antago...

When traditional antidepressants fail older adults with treatment-resistant depression, where can they turn? Standard therapies, built on the monoamine hypothesis, often fall short in aging brains or those affected by neurodegenerative diseases like Alzheimer’s, as the pathways they rely on may be dysfunctional. This episode dives deep into a systematic review exploring a paradigm-shifting alterna...

When traditional antidepressants fail older adults with treatment-resistant depression, where can they turn? Standard therapies, built on the monoamine hypothesis, often fall short in aging brains or those affected by neurodegenerative diseases like Alzheimer's, as the pathways they rely on may be dysfunctional. This episode dives deep into a systematic review exploring a paradigm-shifting alt...

Ketamine is known for its powerful effects on the mind and body, but could one of its most profound secrets be the ability to fight cancer? In this episode, we explore groundbreaking new research that reveals an unexpected link between ketamine and cervical cancer cells. Discover the fascinating mechanism at play: ketamine appears to target the “power plants” (mitochondria) inside cancer cells, fo...

Ketamine is known for its powerful effects on the mind and body, but could one of its most profound secrets be the ability to fight cancer? In this episode, we explore groundbreaking new research that reveals an unexpected link between ketamine and cervical cancer cells.  Discover the fascinating mechanism at play: ketamine appears to target the "power plants" (mitochondria) inside cancer...

Why does ketamine provide miraculous relief for some people with severe depression but leave others behind? This episode unpacks a groundbreaking study that points to a surprising answer: hidden inflammation. Join us as we explore a pioneering 2025 paper that uses a novel method called Intron Retention (IR) to re-examine the biology of ketamine treatment. Researchers discovered that, even before t...

Why does ketamine provide miraculous relief for some people with severe depression but leave others behind? This episode unpacks a groundbreaking study that points to a surprising answer: hidden inflammation. Join us as we explore a pioneering 2025 paper that uses a novel method called Intron Retention (IR) to re-examine the biology of ketamine treatment. Researchers discovered that, even before t...

Ketamine is known for its rapid antidepressant effects, but what if the experience itself could be made more profound and therapeutic? In this episode, we explore new research investigating whether a combination of mindfulness training, music, and an eye mask could enhance the ketamine journey for individuals with clinical depression. While the study found that adding these sensory elements did no...

Ketamine is known for its rapid antidepressant effects, but what if the experience itself could be made more profound and therapeutic? In this episode, we explore new research investigating whether a combination of mindfulness training, music, and an eye mask could enhance the ketamine journey for individuals with clinical depression. While the study found that adding these sensory elements did no...

Can a drug known for pain and mental health treatments also be a weapon against cancer? In this episode of Talking Ketamine , hosts Helios and Selene delve into a surprising new area of research: ketamine and its potential role in fighting cancer. The episode explores a 2024 study on “perioperative ketamine and cancer recurrence” and the complex science behind it. You’ll learn how ketamine’s well-...

Can a drug known for pain and mental health treatments also be a weapon against cancer? In this episode of Talking Ketamine , hosts Helios and Selene delve into a surprising new area of research: ketamine and its potential role in fighting cancer. The episode explores a 2024 study on "perioperative ketamine and cancer recurrence" and the complex science behind it. You'll learn how keta...

Dive into the profound and complex world of ketamine therapy in this episode of the Talking Ketamine podcast, where we explore "The Paradox of Hope". We unpack a powerful qualitative study, "Lived Futures in Ketamine Therapy: A Qualitative Study of Hope and Temporality in Treatment Resistant Depression" , which gives us a raw, unfiltered look into the lives of individuals battling...

Dive into the profound and complex world of ketamine therapy in this episode of the Talking Ketamine podcast, where we explore “The Paradox of Hope”. We unpack a powerful qualitative study, “Lived Futures in Ketamine Therapy: A Qualitative Study of Hope and Temporality in Treatment Resistant Depression” , which gives us a raw, unfiltered look into the lives of individuals battling severe treatment...

Ketamine can lift the fog of severe depression in hours, but what happens when that relief fades just as quickly? This has been the biggest hurdle in using it as a long-term solution for those battling the most persistent and treatment-resistant forms of depression. This episode examines a brand-new 2025 study that explores the groundbreaking strategy of maintenance ketamine infusions. We unpack c...

In this episode, we tackle the complex challenge of co-occurring Major Depressive Disorder (MDD) and Alcohol Use Disorder (AUD). Traditional treatments often fall short, leaving many seeking new hope. This episode unpacks a groundbreaking study by Yoon, Crystal, and colleagues from VA Connecticut and Yale . They explored ketamine’s efficacy in a rigorous, three-arm, double-blind trial with 65 adul...

Welcome to Talking Ketamine, Episode 26, where we’re delving into a fascinating and often overlooked aspect of psychedelic research: the very tone of scientific conversation itself! You know that ketamine and psilocybin are generating immense buzz for their therapeutic potential, especially for tough conditions like treatment-resistant depression. But is the academic literature a unified voice of...